| Dr Thomas Michael Ottavi, PHD | |
|
200 Mercy Dr, Suite 201, Dubuque, IA 52001-7303 | |
| (563) 584-3500 | |
| (563) 584-3520 |
| Full Name | Dr Thomas Michael Ottavi |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 28 Years |
| Location | 200 Mercy Dr, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649220054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 00837 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Clinic Pc | 3870491228 | 192 |
News Archive
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.
Kinetoplastid and apicomplexan parasites include protozoans which are responsible for human diseases, and cause a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms.
Researchers at Hospital for Special Surgery (HSS) have received a grant from the National Institutes of Health to use a novel MRI technique known as magnetic resonance neurography, or MRN, to study Parsonage-Turner Syndrome (PTS), a painful nerve disorder that leads to severe weakness.
The U.S. Supreme Court in November will consider whether to shield the makers of prescription and over-the-counter drugs from liability lawsuits, the Los Angeles Times reports.
› Verified 9 days ago
| Entity Name | Medical Associates Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457300790 PECOS PAC ID: 3870491228 Enrollment ID: O20031223000311 |
News Archive
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.
Kinetoplastid and apicomplexan parasites include protozoans which are responsible for human diseases, and cause a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms.
Researchers at Hospital for Special Surgery (HSS) have received a grant from the National Institutes of Health to use a novel MRI technique known as magnetic resonance neurography, or MRN, to study Parsonage-Turner Syndrome (PTS), a painful nerve disorder that leads to severe weakness.
The U.S. Supreme Court in November will consider whether to shield the makers of prescription and over-the-counter drugs from liability lawsuits, the Los Angeles Times reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Michael Ottavi, PHD 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | Dr Thomas Michael Ottavi, PHD 200 Mercy Dr, Suite 201, Dubuque, IA 52001-7303 Ph: (563) 584-3500 |
News Archive
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.
Kinetoplastid and apicomplexan parasites include protozoans which are responsible for human diseases, and cause a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms.
Researchers at Hospital for Special Surgery (HSS) have received a grant from the National Institutes of Health to use a novel MRI technique known as magnetic resonance neurography, or MRN, to study Parsonage-Turner Syndrome (PTS), a painful nerve disorder that leads to severe weakness.
The U.S. Supreme Court in November will consider whether to shield the makers of prescription and over-the-counter drugs from liability lawsuits, the Los Angeles Times reports.
› Verified 9 days ago
Dr. Aaron Thomas Scott Whitney, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 200 Mercy Dr Ste 201, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 | |
Dr. Daniel L Olson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 700 Locust St, Ste 716, Dubuque, IA 52001 Phone: 563-556-1225 Fax: 563-556-0713 | |
Mr. Paul Joseph Schroeder, EDD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 Mercy Dr, Suite 200, Dubuque, IA 52001 Phone: 563-582-0145 Fax: 563-582-0722 | |
Stephen J. Frommelt, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 | |
Dr. Mary Madeline Johnson, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16306 Forest Gate Rd, Dubuque, IA 52001 Phone: 563-556-7071 | |
Dr. Ann R Ernst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 899 Mount Carmel St, Dubuque, IA 52003 Phone: 563-582-3721 Fax: 563-582-0324 | |
Alec Frederick Anderson, PSY.D, HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Dr Ste 201, Dubuque, IA 52001 Phone: 563-584-3500 Fax: 563-584-3520 |